Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|November 23, 2007
Survivin is highly expressed and promotes cell survival in malignant peritoneal mesotheliomaNadia Zaffaroni, Aurora Costa, Marzia Pennati, et al.Oncotarget|May 8, 2015
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivinMichelandrea De Cesare, Denis Cominetti, Valentina Doldi, et al.Journal of Medicinal Chemistry|July 19, 2016
Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal MesotheliomaVirginia Spanò, Marzia Pennati, Barbara Parrino, et al.Cancer Research|February 27, 2009
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase CepsilonPaolo Gandellini, Marco Folini, Nicole Longoni, et al.Journal of Medicinal Chemistry|August 8, 2013
Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental modelsAnna Carbone, Marzia Pennati, Barbara Parrino, et al.Molecular Cancer|January 23, 2010
miR-21: an oncomir on strike in prostate cancerMarco Folini, Paolo Gandellini, Nicole Longoni, et al.Cells|October 7, 2020
Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific AntibodySilvia Martini, Mariangela Figini, Aurora Croce, et al.Oncogene|January 16, 2004
Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cellsMarzia Pennati, Mara Binda, Gennaro Colella, et al.Cancer Cell|May 17, 2005
Rational design of shepherdin, a novel anticancer agentJanet Plescia, Whitney Salz, Fang Xia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathwaysElena Tassi, Marina Zanon, Claudia Vegetti, et al.Pageof 5